arrow
A

Anna Brown

South Australia Pathology
H指数:41
被引数:5,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upfront whole genome and transcriptome sequencing to improve diagnosis in inherited bone marrow failure syndromes

upfront全基因组与转录组测序以改善遗传性骨髓衰竭综合征的诊断

Blood
IF23.1
2026-01-010
OAAI
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm

RAS突变识别出治疗相关性髓系肿瘤的不良预后分子亚型

2025-05-260
OA
RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome

Wiseman, T.; Spooner, M.; Khanna, S.; Hung, K.; Toop, C.; Kutyna, M.M.; Yu, J.; Brown, A.L.; Scott, H.S.; Hahn, C.N.; et al. 红细胞输注依赖性优化了骨髓增生异常综合征的分子国际预后评分系统。Blood Adv. 2025. [Google Scholar] [CrossRef]

2025-04-250
OAAI
CBL Variants in Chronic Myelomonocytic Leukemia Exhibit a Complex Sub-Clone Architecture with a High Frequency of RING Domain Mutations Sufficient to Induce GM-CSF Hypersensitivity

CBL变体在慢性髓系单核细胞白血病中表现出复杂的亚克隆结构,并伴有高频RING结构域突变,足以诱导GM-CSF高敏感性。

BLOOD
IF23.1
2024-11-050
PRE
Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features
2024-07-190
OAAI
Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion
2024-06-271
PRE
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
2023-10-1213
OAAI
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
2023-04-1116
OAAI
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

成人遗传性髓系恶性肿瘤的异基因造血干细胞移植结局

2023-02-1729
OAAI
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms
2023-02-011
PRE
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia (vol 13, 2614, 2022)
2022-07-152
OAAI
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
2022-05-1213
OAAI
Abemaciclib and endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: A real-world UK multicentre experience
2022-02-150
PRE
GATA2 deficiency syndrome: A decade of discovery
2021-08-3139
OAAI